Department of Bioproducts and Biosystems (BIO(2)), PO Box 16300, FI-00076, Aalto University, Finland.
Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, P.O. Box 56, 00014 Helsinki, Finland.
Int J Pharm. 2018 Sep 5;548(1):113-119. doi: 10.1016/j.ijpharm.2018.06.022. Epub 2018 Jun 18.
Drug release from a new type of matrix material consisting of partially fibrillated microcrystalline cellulose was investigated. A mechanical treatment of novel AaltoCell™ cellulose microcrystals caused partial opening of the nanofibrillary structure of the cellulose particles and entanglement of individual particles led into formation of an elastic network of microcrystalline cellulose. The rheological properties of the stable hydrogel-like materials were characterised by shear rheometry. Model compounds metronidazole and lysozyme were successfully employed in drug release experiments carried out by delignified (bleached) and lignin-containing matrices. The viscosity as well as the lignin-content played a role in the release dynamics of the drugs. Microcrystalline AaltoCell™ was proven as high-performing material for diffusion controlled release of the chosen model compounds and can be seen as a safe and economical alternative for novel matrix materials such as nanocellulose or cellulose derivatives.
研究了由部分纤维化微晶纤维素组成的新型基质材料的药物释放。新型 AaltoCell™纤维素微晶的机械处理导致纤维素颗粒的纳米纤维结构部分打开,并且单个颗粒的缠结导致微晶纤维素的弹性网络形成。通过剪切流变学对稳定的凝胶状材料的流变性质进行了表征。将米诺环素和溶菌酶这两种模型化合物成功地用于通过脱木质素(漂白)和含木质素的基质进行的药物释放实验。药物释放动力学中,粘度和木质素含量都起着作用。微晶 AaltoCell™被证明是扩散控制释放所选模型化合物的高性能材料,并且可以被视为新型基质材料(如纳米纤维素或纤维素衍生物)的安全且经济的替代品。